[Effect of euphylline, berotec, and atrovent on the oxygen content and acid-base balance of patients with lung diseases].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000628:Aminophylline / Q000627:therapeutic use*; D001286:Atropine Derivatives / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D005280:Fenoterol / Q000627:therapeutic use*; D006801:Humans; D009241:Ipratropium / Q000627:therapeutic use*; D008171:Lung Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use*
D001286:Atropine Derivatives; D001993:Bronchodilator Agents; D004983:Ethanolamines; D010276:Parasympatholytics; D005280:Fenoterol; D000628:Aminophylline; D009241:Ipratropium
Vliianie éufillina, beroteka i atroventa na kislorodnyĭ sostav i kislotno-shchelochnoe ravnovesie krovi u bol'nykh s zabolevaniiami legkikh.